Delivery Order SPE2DB20D1102-SPE2DB24FC6JC
- Not listed
- This federal contract award, valued at $1,326.21, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The award covers the delivery of CIPROFLOX-DEXAMETH OTIC SUSP 7.5ML, a pharmaceutical product, with an ultimate completion date of January 16, 2024. The contract is a Delivery Order under a Firm Fixed Price structure, with no set-aside designation. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order worth $4,545.32 for the supply of CIPROFLOX-DEXAMETH OTIC SUSP 7.5ML. The award was made by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of January 19, 2024. The contract is a Firm Fixed Price Delivery Order and was not set aside for any specific business type. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
- This federal contract award, valued at $1,401.31, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of CIPROFLOX-DEXAMETH OTIC SUSP 7.5ML, a pharmaceutical product. The contract has an ultimate completion date of November 9, 2023 and is a Firm Fixed Price Delivery Order. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen's parent company, Cencora, Inc.,...
- This federal contract award, valued at $2,362.38, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of CIPROFLOX-DEXAMETH OTIC SUSP 7.5ML, a pharmaceutical product, and has a completion date of July 12, 2024. The contract is a Delivery Order under the terms of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $3,394.19, is for the delivery of CIPROFLOX-DEXAMETH OTIC SUSP 7.5ML, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of April 4, 2025. The contract was not set aside for any specific business type. AmerisourceBergen Drug Corp holds a significant $999,999,999 Indefinite...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,197.07 delivery order covers the supply of CIPROFLOX-DEXAMETH OTIC SUSP 7.5ML, a pharmaceutical product, with a performance period through May 16, 2024. The contract is a firm fixed-price delivery order and was not set aside for any specific business category. AmerisourceBergen Drug Corp holds a $999,999,999...
- This federal contract award, valued at $6,978.82, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The contract is for the delivery of CIPROFLOX-DEXAMETH OTIC SUSP 7.5ML, a pharmaceutical product, with a completion date of July 3, 2024. This contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31,...
- This federal contract award, valued at $1,194.91, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of CIPROFLOX-DEXAMETH OTIC SUSP 7.5ML, a pharmaceutical product, with an ultimate completion date of May 19, 2023. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,532.54, is for the delivery of CIPROFLOX-DEXAMETH OTIC SUSP 7.5ML, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order, without any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company, Cencora, Inc.,...
- The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the supply of CIPROFLOX-DEXAMETH OTIC SUSP 7.5ML, with a ceiling value of $7,892.63 and an ultimate completion date of February 6, 2024. This contract award is not designated as a set-aside. Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is the prime contractor with no major subcontractors listed. The...
- SPE2DB20D1102Indefinite Delivery Contract
- SPE2DB20D1102-SPE2DB24FC6JCDelivery Order
This federal contract award, valued at $2,077.12, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of CIPROFLOX-DEXAMETH OTIC SUSP 7.5ML, a pharmaceutical product, with a completion date of May 1, 2024. The contract is a delivery order and has a firm fixed price pricing type. It is not designated as a set-aside contract. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.1k | 4/30/24 |